Identification of FOXH1 mutations in patients with sporadic conotruncal heart defect.

Related Articles

Identification of FOXH1 mutations in patients with sporadic conotruncal heart defect.

Clin Genet. 2020 Jan 31;:

Authors: Wei W, Li B, Li F, Sun K, Jiang X, Xu R

Conotruncal heart defects (CTD) are an important subtype of congenital heart disease that occur due to abnormality in the development of the cardiac outflow tract (OFT). FOXH1 is a transcription factor that participates in the morphogenesis of the right ventricle (RV) and OFT. In this study, we confirmed the expression of FOXH1 in mouse and human embryos during OFT development. We also scanned the coding exons and splicing regions of the FOXH1 gene in 605 patients with sporadic CTD and 300 unaffected controls, from which we identified 7 heterozygous FOXH1 gene mutations. According to bioinformatics analysis results, they were predicted potentially deleterious at conserved amino acid sites. Western blot was used to demonstrate that all the variants decreased the expression of FOXH1 protein, while dual-luciferase reporter assay showed that six of them, with an exception of p.P35R, had enhanced abilities to modulate the expression of MEF2C, which interacts with NKX2.5 and is involved in cardiac growth. The EMSA result showed that two mutations altered DNA-binding abilities of mutant FOXH1 proteins. Phenotype heterogeneity was found in patients with the same mutation. These results indicate that FOXH1 mutations lead to disease-causing functional changes that contribute to the occurrence of CTD. This article is protected by copyright. All rights reserved.

PMID: 32003456 [PubMed – as supplied by publisher]

Source link

Related posts

JACC Instructions for Authors


Podcast: Exercise is Medicine for Your Heart


Smoking and diabetes ‘risk factors’ for calcium buildup in brain


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy